Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02608385
Title Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

renal cell carcinoma

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.